Showing results (121-130 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|July 18, 2018
Age-related changes in hepatic expression and activity of drug metabolizing enzymes in male wild-type and breast cancer resistance protein knockout miceHaihui Zheng, Liping Wang, Sijing Zeng, et al.Biopharmaceutics & Drug Disposition|May 4, 2022
Optimizing transcardial perfusion of small molecules and biologics for brain penetration and biodistribution studies in rodentsKeumhan Noh, Xingrong Liu, Cong WeiBiopharmaceutics & Drug Disposition|January 1, 1987
Correlation between inhibitory effect on platelet aggregation and disposition of sulfinpyrazone and its metabolites in rabbits. Part II: Multiple dose studyB S Kuo, W A RitschelBiopharmaceutics & Drug Disposition|January 1, 1987
The bioavailability of oral nifedipine formulations: a statistical and simulation approachF Kozjek, S Primozic, A Mrhar, et al.Biopharmaceutics & Drug Disposition|January 1, 1987
Determination of isosorbide dinitrate biotransformation in various tissues of the rabbit by capillary column gas-liquid chromatographyG S Tam, K Nakatsu, J F Brien, et al.Biopharmaceutics & Drug Disposition|January 1, 1987
Definition of mean residence times in pharmacokineticsD J CutlerBiopharmaceutics & Drug Disposition|July 12, 2019
Pharmacokinetic modeling of the blood-stable camptothecin analog AR-67 in two different formulationsXiaoxi Liu, Eyob Adane, Fei Tang, et al.Biopharmaceutics & Drug Disposition|July 1, 2019
Prediction of clinical effects of infliximab administered for inflammatory bowel disease based on pharmacokinetic and pharmacodynamic modelingKoji Kimura, Atsushi Yoshida, Fumihiko Katagiri, et al.Biopharmaceutics & Drug Disposition|February 23, 2022
Metabolism, pharmacokinetics, and anticonvulsant activity of a deuterated analog of the α2/3-selective GABAkine KRM-II-81Lalit K Golani, Branka Divović, Dishary Sharmin, et al.Biopharmaceutics & Drug Disposition|April 11, 2022
Physiologically based pharmacokinetic modeling and simulations to inform dissolution specifications and clinical relevance of release rates on elagolix exposureDwaipayan Mukherjee, Manoj S Chiney, Xi Shao, et al.Pageof 214